# Afamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective.

> PubMed lists PMID 40692281 in Clinical and experimental dermatology as Journal Article, with publication-date metadata of 2025-10-27 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-40692281-afamelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-10-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40692281-afamelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-40692281-afamelanotide-v1.json
- Content SHA-256: `42889f5d6794be00687b6385405ed40381956d47597f2c877120fedafd550b0b`

## Claims and source pins

### Headline

Afamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective. ([`pubmed-observation-pmid-40692281-2025-10-27-38c5d5331086`](#source-pubmed-observation-pmid-40692281-2025-10-27-38c5d5331086))

### Summary

PubMed lists PMID 40692281 in Clinical and experimental dermatology as Journal Article, with publication-date metadata of 2025-10-27 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40692281-2025-10-27-38c5d5331086`](#source-pubmed-observation-pmid-40692281-2025-10-27-38c5d5331086))

### Paragraph 1

PubMed lists PMID 40692281 in Clinical and experimental dermatology as Journal Article, with publication-date metadata of 2025-10-27 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40692281-2025-10-27-38c5d5331086`](#source-pubmed-observation-pmid-40692281-2025-10-27-38c5d5331086))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40692281-2025-10-27-38c5d5331086`](#source-pubmed-observation-pmid-40692281-2025-10-27-38c5d5331086))

## Sources

<a id="source-pubmed-observation-pmid-40692281-2025-10-27-38c5d5331086"></a>
- **Afamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective. · retained source version 1:2025-10-27:current:38c5d53310863af3e8e10264961443dffed6fb3354711c49badf9531200e7d33** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40692281/) (`pubmed-observation-pmid-40692281-2025-10-27-38c5d5331086`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Afamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-40692281-afamelanotide-v1.json SHA-256: 42889f5d6794be00687b6385405ed40381956d47597f2c877120fedafd550b0b.